Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40K Sell
2,199
-132
-6% -$2.82K 0.02% 905
2026
Q1
$47K Buy
+2,331
New +$51.8K 0.03% 742
2025
Q2
Sell
-6,984
Closed -$90K 2145
2025
Q1
$90K Buy
6,984
+922
+15% +$14.8K 0.06% 553
2024
Q4
$104K Buy
6,062
+580
+11% +$11.6K 0.07% 502
2024
Q3
$124K Buy
5,482
+1,032
+23% +$23.6K 0.08% 395
2024
Q2
$110K Buy
4,450
+1,143
+35% +$32.5K 0.07% 427
2024
Q1
$109K Buy
3,307
+2,210
+201% +$75.2K 0.07% 482
2023
Q4
$40K Buy
1,097
+136
+14% +$4.67K 0.03% 943
2023
Q3
$35K Sell
961
-73
-7% -$2.91K 0.03% 905
2023
Q2
$40K Buy
1,034
+61
+6% +$2.25K 0.03% 867
2023
Q1
$40K Sell
973
-72
-7% -$3.01K 0.03% 789
2022
Q4
$36K Sell
1,045
-39
-4% -$1.36K 0.03% 850
2022
Q3
$30K Buy
1,084
+6
+0.6% +$195 0.03% 888
2022
Q2
$32K Sell
1,078
-322
-23% -$10.8K 0.03% 861
2022
Q1
$57K Buy
1,400
+17
+1% +$730 0.04% 758
2021
Q4
$66K Buy
+1,383
New +$62K 0.09% 362

Other funds holding ADNT

Covestor's ADNT Position: Q2 2026 in Review

Covestor reduced its Adient (ADNT) stake by 5.7% in Q2 2026, selling an estimated $2.82K and leaving 2,199 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #905.

Covestor first reported a position in ADNT in Q4 2021 and has held it in 16 quarters since. The position peaked at $124K in Q3 2024. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Covestor held 2,199 shares of Adient worth $40K as of Q2 2026.
  • Covestor sold 132 Adient shares in Q2 2026, an estimated $2.82K.
  • Adient made up 0.02% of Covestor's portfolio in Q2 2026, its #905 holding.
  • Covestor first reported a position in Adient in Q4 2021 and has held it in 16 quarters since.
  • Covestor's Adient position peaked at $124K in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.